Fortis Advisors, LLC Novo Nordisk A S Transaction History

Fortis Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $2.43 Million - $3.07 Million	28,803 New	28,803 $29,000
Q3 2020 Nov 13, 2020	SELL	$63.69 - $70.22 $8,789 - $9,690	-138 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$46.76 - $51.24 $3,366 - $3,689	-72 Reduced 34.29%	138 $7,000
Q1 2018 May 11, 2018	BUY	$48.49 - $58.14 $6,691 - $8,023	138 Added 191.67%	210 $10,000
Q3 2017 Nov 14, 2017	BUY	$41.15 - $49.22 $2,962 - $3,543	72	72 $3,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Fortis Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fortis Advisors, LLC with notifications on news.